2652-0293 Screening compound: 2-phenyl-N-[2-(2-phenylacetamido)-1,3-benzothiazol-6-yl]acetamide

2652-0293 Screening compound: 2-phenyl-N-[2-(2-phenylacetamido)-1,3-benzothiazol-6-yl]acetamide
2652-0293 Screening compound: 2-phenyl-N-[2-(2-phenylacetamido)-1,3-benzothiazol-6-yl]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound 2652-0293
2-phenyl-N-[2-(2-phenylacetamido)-1,3-benzothiazol-6-yl]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

2652-0293

Molecular Formula

C23H19N3O2S (C23 H19 N3 O2 S)

Compound Name

2-phenyl-N-[2-(2-phenylacetamido)-1,3-benzothiazol-6-yl]acetamide

IUPAC name

2-phenyl-N-[2-(2-phenylacetamido)-13-benzothiazol-6-yl]acetamide

SMILES

O=C(Cc1ccccc1)Nc1nc(ccc(NC(Cc2ccccc2)=O)c2)c2s1

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

401.49

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

4.509

Distribution Coefficient, logD

4.508

Water Solubility, LogSw

-4.43

Polar Surface Area

55.755

Acid Dissociation Constant (pKa)

10.51

Base Dissociation Constant (pKb)

2.68

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

8.70

2652-0293 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Anti-infective Library (19449 compounds)

Antiviral Library (67538 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Infections
  • Immune system
  • animal
  • Antiviral
  • Infections
  • Immune system
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Kinases
  • Proteases

References: we are preparing a list of scientific research reports with 2652-0293 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 2652-0293?
Check Price and Availability of 2652-0293, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 2652-0293 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 2652-0293
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 2652-0293
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 2652-0293 available by request